REVISED: SpectraScience to Present at the LHA Life Sciences & Medtech Virtual Conference on February 16
(firmenpresse) - SAN DIEGO, CA -- (Marketwire) -- 02/13/12 -- SpectraScience, Inc. (OTCQB: SCIE) (PINKSHEETS: SCIE), a San Diego based medical device company, today announced that Chief Executive Officer Michael Oliver will present to investors as part of the LHA Life Sciences & Medical Technologies Virtual Conference on Thursday, February 16, 2012, at Noon Eastern time.
A webcast of the presentation will be accessible online at the PrecisionIR event site: . An archived version will be available for 30 days.
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.
Contact:
SpectraScience, Inc.
Jim Dorst
Chief Financial Officer
(858) 405-9933
Investor Relations
LHA
Don Markley
(310) 691-7100
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 13.02.2012 - 19:21 Uhr
Sprache: Deutsch
News-ID 113987
Anzahl Zeichen: 0
contact information:
Town:
SAN DIEGO, CA
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 200 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"REVISED: SpectraScience to Present at the LHA Life Sciences & Medtech Virtual Conference on February 16"
steht unter der journalistisch-redaktionellen Verantwortung von
SpectraScience, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
